The lipopolysaccharide (LPS) 1 layer is an essential outer membrane glycolipid located on the cellular surface of virtually all Gram-negative bacteria (1). The LPS contains three principle elements: lipid A, the core oligosaccharide, and the Oantigen. The core oligosaccharide provides the link between the highly conserved membrane-imbedded lipid A and the structurally diverse complex carbohydrate O-antigen chain (2) and can be further subdivided into the inner and outer core regions. Whereas the structure of the outer core is somewhat variable, the inner core is highly conserved, being primarily composed of L-glycero-D-manno-heptose and 3-deoxy-D-manno-octulosonate (KDO) residues (3). This suggests the importance of the inner core-lipid A complex in maintaining the structural integrity and viability of the cell (4). In addition, it has been shown that the minimal LPS required to sustain growth in mutant Escherichia coli strains consists of the KDO 2 -lipid A core (Re endotoxin) (5, 6), that the interruption of KDO biosynthesis leads to the arrest of cell growth (7-9), and that cells containing a compromised LPS are generally less pathogenic and more susceptible to antibiotics (10, 11). Accordingly, enzymes involved in the biosynthesis of KDO are attractive targets for the development of specific antibiotics because of their localization to and high level of conservation within Gram-negative bacteria.The synthesis and activation of KDO involves four sequentially acting enzymes: D-arabinose 5-phosphate isomerase (API), deoxy-D-manno-octulosonate 8-phosphate (KDO 8-P) synthase, KDO 8-P phosphatase, and cytidine 5Ј-monophosphate-KDO synthetase ( Fig. 1) (12, 13). The first committed step to KDO generation is catalyzed by 3-deoxy-D-manno-octulosonate 8-phosphate (KDO 8-P) synthase, which condenses D-arabinose 5-phosphate (A5P) with phosphoenolpyruvate via a stereospecific aldol-type condensation (14, 15). A5P is the first intermediate unique to the KDO biosynthetic pathway, and API is the main de novo source of A5P in Gram-negative bacteria, because it is not readily available via glycolysis (16). API synthesizes A5P by catalyzing the reversible aldol-keto isomerization of D-ribulose 5-phosphate (Ru5P) to A5P (Fig. 1). It is reasonable to speculate that inhibition of API will have similar cellular effects as direct KDO synthase inhibition (7-9), thus providing another viable Gram-negative antibiotic target from the KDO pathway.The gene(s) encoding API in E. coli K-12 has yet to be positively identified. Recent work in this laboratory provided evidence that the open reading frame (ORF) yrbI encoded a 188-amino acid phosphatase that was highly specific for KDO 8-P (17). Analysis of the E. coli K-12 MG1655 genome (18) at the National Center for Biotechnology Information (NCBI) web site revealed an ORF (yrbH) located next to yrbI in the yrb cluster encoding a putative phosphosugar isomerase. The yrbH gene was cloned, overexpressed, and purified to homogeneity. Utilizing a newly developed 96-well microplate assay, the rec...